• LAST PRICE
    0.6001
  • TODAY'S CHANGE (%)
    Trending Down-0.0105 (-1.7196%)
  • Bid / Lots
    0.5900/ 7
  • Ask / Lots
    0.6200/ 9
  • Open / Previous Close
    0.5988 / 0.6106
  • Day Range
    Low 0.5876
    High 0.6240
  • 52 Week Range
    Low 0.5000
    High 21.5000
  • Volume
    56,633
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.6106
TimeVolumeMTNB
09:32 ET15960.59
09:37 ET202670.624
09:50 ET11400.5876
09:53 ET3000.5876
10:00 ET14000.5938
10:02 ET3400.611
10:13 ET3000.6011
10:15 ET23000.6
10:27 ET2000.5931
10:31 ET2860.5896
11:00 ET7410.5895
11:12 ET1000.599
11:18 ET10000.5897
11:27 ET7690.599
11:36 ET57010.6
11:38 ET3070.5999
11:52 ET1290.5999
12:12 ET20000.5901
12:14 ET5000.61
12:15 ET39000.611
12:17 ET2430.6145
12:21 ET1830.62
12:24 ET9170.62
12:30 ET1570.6033
12:33 ET4000.6201
12:35 ET9900.6147
12:39 ET2860.6101
12:42 ET5000.6101
12:53 ET11000.6101
01:06 ET1000.6101
01:18 ET3000.5991
01:22 ET11000.5991
01:24 ET6000.591
01:26 ET11000.591
01:45 ET1000.605
01:56 ET1000.6
02:21 ET9340.6
02:39 ET1000.6
03:03 ET2000.6001
03:08 ET2000.610001
03:10 ET1000.619
03:37 ET1000.6102
03:53 ET1000.61
04:00 ET5320.6001
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMTNB
Matinas BioPharma Holdings Inc
3.1M
-0.1x
---
United StatesKLDO
Kaleido Biosciences Inc
4.3K
0.0x
---
United StatesAZTR
Azitra Inc
3.7M
-0.1x
---
United StatesBDRX
Biodexa Pharmaceuticals PLC
2.7M
0.0x
---
United StatesONCT
Oncternal Therapeutics Inc
1.6M
0.0x
---
United StatesMYMX
Mymetics Corp
150.0
0.0x
---
As of 2024-12-11

Company Information

Matinas BioPharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology (LNC Platform). Its lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. MAT2203 is now positioned for a single, Phase III registration trial (the ORALTO trial) in support of a New Drug Application (NDA) for the treatment of invasive aspergillosis in patients with limited treatment options. It is expanding the utilization of the LNC Platform with small molecules and small oligonucleotides outside of infectious disease, targeting inflammation and oncology. It is also investigating a variety of LNC formulations of two small oligonucleotides designed to target inflammatory cytokines IL-17A and TNFα.

Contact Information

Headquarters
Suite 302, 1545 Route 206 SouthBEDMINSTER, NJ, United States 07921
Phone
908-443-1860
Fax
302-636-5454

Executives

Independent Chairman of the Board
Eric Ende
President, Chief Executive Officer, Director
Jerome Jabbour
Chief Financial Officer
Keith Kucinski
Chief Technology Officer
Hui Liu
Chief Business Officer
Thomas Hoover

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.1M
Revenue (TTM)
$0.00
Shares Outstanding
5.1M
Matinas BioPharma Holdings Inc does not pay a dividend.
Beta
1.59
EPS
$-4.56
Book Value
$4.43
P/E Ratio
-0.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.